ArticleFrontiers in psychiatry2022

Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial.

Marco Aurélio Cigognini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.